Detection of Binding Sites on SARS-CoV-2 Spike Protein Receptor-Binding Domain by Molecular Dynamics Simulations in Mixed Solvents

The novel SARS-CoV-2 uses ACE2 (Angiotensin-Converting Enzyme 2) receptor as an entry point. Insights on S protein receptor-binding domain (RBD) interaction with ACE2 receptor and drug repurposing has accelerated drug discovery for the novel SARS-CoV-2 infection. Finding small molecule binding sites...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IEEE 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791430/
https://www.ncbi.nlm.nih.gov/pubmed/33914685
http://dx.doi.org/10.1109/TCBB.2021.3076259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791430/
https://www.ncbi.nlm.nih.gov/pubmed/33914685
http://dx.doi.org/10.1109/TCBB.2021.3076259

Ejemplares similares